Inotiv, Inc. — Director's Dealing 2004

Mar 2, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2004-02-27

Reporting Person: NOONE MICHAEL S (Dir. of Clinical Affairs, Balt)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-02-27	Option to Buy Common Shares	$4.511	A	20000	Acquired	2014-02-27	Common Shares (20000)	Direct

Footnotes

F1: 50% of the grant is exercisable one (1) year after the transaction date; the remaining 50% is exercisable three (3) years after the transaction date.